What does EYE-SYNC cost?

Subscription-based FDA-cleared eye-tracking platform for concussion diagnosis; pricing available only through direct vendor contact.

EYE-SYNC is a subscription-based neurodiagnostic platform with no publicly available list price. There is no fee per test once deployed, but the upfront and annual costs of the system—hardware, software licensing, training, and support—remain opaque. Procurement officers should expect to pay for: a VR headset with integrated eye-tracking technology, proprietary software access, mandatory clinician certification, and ongoing technical support. Total cost of acquisition likely falls in the $50,000–$200,000+ range depending on deployment model and volume, but this estimate is based on comparable medical diagnostic systems and clinical IT infrastructure—not on published EYE-SYNC pricing. MedSource does not yet have aggregate quote data for this product. This article will be updated as pricing quotes accrue.

What the typical range is

No aggregate data exists. The pricing model is subscription-based, with details available upon request; contact vendor for pricing information. Industry comparisons offer limited guidance: high-end research eye-trackers (EyeLink 1000 series, Tobii systems) typically retail for $3,000–$15,000 per unit, but EYE-SYNC bundles software, cloud storage, HIPAA compliance, and clinician certification—substantially raising the total cost of ownership.

For context, remote eye trackers range from $2,000–$10,000+, with sampling rate, precision, and monocular vs. binocular tracking as major differentiators; software contributes to cost, and you may pay for upgrades to access advanced analytics tools, integrations, and data storage; training and/or support is usually required. EYE-SYNC's clinical-grade analytics and regulatory clearance position it at the premium end of this spectrum.

What pushes price up — features, certifications, support tier

FDA Clearance and Regulatory Status

The FDA cleared EYE-SYNC for viewing, recording, and analyzing eye movements in support of visual impairment identification in 2016; the FDA selected EYE-SYNC as Breakthrough Device Designation for aid to concussion assessment in 2019; the FDA cleared EYE-SYNC as an aid to concussion diagnosis in 2021. This multi-clearance pathway adds validation cost that is passed through to buyers.

Clinical Evidence & Peer Review

The platform uses a series of 60-second assessments with more than 30 published peer-reviewed papers and 16 granted patents.

The study showed EYE-SYNC demonstrated sensitivity above 82% and specificity above 93%, thereby providing clinicians with significant and actionable data when evaluating individuals with concussion. Licensing proprietary algorithms and a 15-year research database is costly.

Mandatory Clinician Certification & Training

All providers who implement the EYE-SYNC technology go through an initial training and onboarding process; training is provided by NeuroSync clinical experts, and those experts are responsible for certifying users. In-person training at your site (vs. remote) adds labor and travel costs.

Cloud Infrastructure & Data Security

All data captured is encrypted end to end and stored in a HIPAA compliant cloud, where results can be exported via PDF or through secure data transfer through our API. Cloud hosting, encryption, audit logging, and HIPAA compliance infrastructure increase operating costs.

Extended Reality (XR) Hardware Integration

The proprietary software and analytics tools combined with the use of Extended Reality (XR) headsets allow accurate and reliable detection of eye movements to quantify impairment. Earlier versions ran on Samsung Gear VR; the Pico Neo 2 Eye, released in early 2020 and equipped with Tobii eye tracking technology, meets requirements for portability, battery life, and native eye tracking. Specialized hardware integration increases upfront cost.

What pushes price down — refurbished, older generation, lease, GPO contracts

Limited Used Market
EYE-SYNC is a relatively young, proprietary platform with limited refurbished equipment availability. Earlier generations (Samsung Gear VR-based; 2017–2019) may trade at lower prices but lack current FDA indications and lack hardware support.

Subscription vs. Purchase Models

Pricing model is subscription-based. Negotiating multi-year subscriptions or volume discounts is standard for institutional buyers, but no published tiering is disclosed. Group purchasing organizations (GPOs) may negotiate rates, but EYE-SYNC is not listed on major GPO contracts (Vizient, Medline, Premier) at this writing.

Trial Programs

If interested in a trial period to further evaluate the EYE-SYNC technology, please contact us directly. Proof-of-concept deployments may reduce initial capital outlay and allow phased adoption.

No Per-Test Fees

There is no fee per test; use EYE-SYNC as often as you like anywhere you go. This is a significant advantage over some competing diagnostic platforms that charge per-assessment licensing. High-volume users (sports medicine programs, concussion clinics) see marginal cost approaching zero after deployment.

Hidden costs — install, training, calibration, consumables, service contracts

Mandatory Clinician Certification

All users are formally trained on the EYE-SYNC technology; this service is provided, on most occasions, in person and at the site of your clinical care environment. Budget $2,000–$5,000 for initial on-site training and travel, plus staff time for multiple clinicians.

IT Infrastructure & Networking
EYE-SYNC requires secure Bluetooth connectivity, cloud API integration, and EMR data export. Hospital IT departments may incur costs for network configuration, firewall rules, and compliance audits (especially if data flows through Epic, Cerner, or other EHRs).

Hardware Replacement
VR headsets (Pico Neo 2 Eye or similar) have ~2–3 year hardware lifecycles. Budget replacement or repair costs outside warranty, particularly for high-use environments (athletic training rooms, emergency departments).

Ongoing Clinical & Technical Support

In addition to hardware/software purchase, real time clinical and technical support is provided as often as needed; clinical experts support test administration workflows, protocol design, and result interpretation; unlimited access to the NeuroSync Knowledge Base is provided. This support tier is likely bundled into subscription but may have tiered SLA options (response time, availability).

Data Storage & API Fees
Long-term data archiving in HIPAA-compliant cloud storage may incur incremental costs based on volume and retention period. API-based data transfer to third-party systems may carry additional licensing.

How to negotiate — concrete tactics

1. Demand Transparency Early
   Request a formal quote tied to your use case: number of clinicians, expected monthly assessments, desired response-time SLA, and integration scope. Avoid vague "contact sales" loops.

2. Bundle Hardware & Software
   Clarify whether the VR headset is sold separately or included. If separate, negotiate as a system (EYE-SYNC software + Pico headset or equivalent) and avoid split invoicing that obscures true cost.

3. Volume & Multi-Year Discounts
   If you plan to deploy across multiple clinical sites or departments, negotiate a site license or enterprise agreement. Multi-year commitments typically unlock 10–25% discounts.

4. Proof-of-Concept Terms
   Propose a 60–90 day trial for one clinic with explicit pricing for continuation or termination. This reduces deployment risk and gives you a real cost model.

5. Support & Certification Scope
   Clarify training costs upfront: number of clinicians certified, in-person vs. virtual, and whether re-certification (annual compliance, new staff) is included or billed separately. Negotiate one bundled training for multiple staff.

6. API & Integration Fees
   If you need EMR integration or analytics dashboards beyond the standard portal, request a fixed integration fee and avoid per-user or per-API-call pricing.

7. Hardware Refresh Policy
   Negotiate terms for VR headset replacement (e.g., 3-year hardware refresh cycle, refurbished or new units at discounted cost).

8. Benchmark Competitive Platforms
   While no direct EYE-SYNC competitor offers identical functionality, gather quotes from visual impairment assessment platforms (RightEye, NeuroCom, other vestibular/oculomotor diagnostic systems) to inform your negotiation leverage.

When the price feels off — red flags

• Vendor Refuses Written Quote: Any vendor declining to provide a formal quote after discovery calls is likely using opacity to prevent competitive shopping. Escalate to a CFO or demand engagement with a sales engineer with authority to price.

• Hidden Per-Test or Per-User Fees: Confirm in writing that there is no fee per test. Any vendor suggesting variable costs per assessment is misrepresenting the model.

• Training Costs Not Included or Undefined: If initial clinician certification is presented as a separate line item with no cap, demand a fixed all-in training cost or risk unlimited expenses.

• No Multi-Site or Multi-Year Pricing: Enterprise hospital systems deploying across multiple departments should never accept single-site pricing. Lack of volume flexibility signals unwillingness to negotiate.

• Ambiguous Cloud Storage Terms: Ensure HIPAA compliance, data retention policy, and archival costs are explicitly documented. If the vendor won't quantify annual cloud fees, assume they'll escalate them later.

• Hardware Bundled at Premium: If EYE-SYNC includes a VR headset (Pico Neo 2 Eye) at retail markup, negotiate separately. Pico headsets wholesale ~$400–$600; bundle pricing above $1,200 per unit is likely padded.

• Support SLAs Below 24-Hour Response: For clinical diagnostic systems, accept no worse than next-business-day support. Longer response times for a concussion assessment tool are unacceptable.

Sources

FDA clearances (2016, 2019, 2021) documented on NeuroSync.health

FDA 510(k) Substantial Equivalence Determination (K202927, October 2, 2021)

Clinical validation study: 1,655 subjects; sensitivity 82%+, specificity 93%+ (NeuroSync, 2021)

Hardware specification: Pico Neo 2 Eye with Tobii eye tracking (Tobii.com, 2020)

Pricing model and contact information (HealthAidb, May 2025)

Disclaimer: EYE-SYNC pricing is not publicly disclosed. This article is based on regulatory filings, hardware specifications, and comparable diagnostic platform costs. Actual procurement costs will vary based on deployment model, volume, support tier, and negotiation. Request formal quotes from NeuroSync directly. MedSource will update this analysis as institutional pricing data accumulates.